Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
163 hedge funds and large institutions have $880M invested in Meridian Bioscience Inc in 2013 Q2 according to their latest regulatory filings, with 163 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
593% more call options, than puts
Call options by funds: $478K | Put options by funds: $69K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RNS
151
Robert N. Shapiro
| $23K | +$23.2K | +1,075 | New |
|
|
WBC
152
Westpac Banking Corp
Sydney,
Australia
| $22.8K | +$21.6K | +1,000 | New |
|
153
KBC Group
Brussels,
Belgium
| $17K | +$17.1K | +792 | New |
|
|
OMCS
154
Old Mutual Customised Solutions
Pinelands,
South Africa
| $15K | +$15.1K | +700 | New |
|
155
Citigroup
New York
| $12K | +$11.8K | +546 | New |
|
|
PSC
156
Prentiss Smith & Co
Brattleboro,
Vermont
| $9K | +$8.63K | +400 | New |
|
|
AAM
157
Advisors Asset Management
Monument,
Colorado
| $8K | +$8.07K | +374 | New |
|
|
TRCT
158
Tower Research Capital (TRC)
New York
| $6K | +$6.47K | +300 | New |
|
|
HRIA
159
Haberer Registered Investment Advisor
Cincinnati,
Ohio
| $5K | +$5.48K | +254 | New |
|
|
AA
160
AlphaMark Advisors
Ft. Wright,
Kentucky
| $4K | +$4.16K | +193 | New |
|
|
SCM
161
Siphron Capital Management
Beverly Hills,
California
| $2K | +$2.07K | +96 | New |
|
|
SMA
162
Simply Money Advisors
Cincinnati,
Ohio
| $1K | +$647 | +30 | New |
|
163
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $327 | +$328K | +15,200 | New |
|
VIVO Hedge Fund Activity: Q2 2013 in Review
163 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2013, worth a combined $880M.
Buyers outnumbered sellers: 163 funds opened new VIVO positions and 0 closed out — a net gain of 163 holders — while 0 added to existing stakes and 0 trimmed.
- 163 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $880M of Meridian Bioscience Inc stock for Q2 2013.
- 163 funds opened new Meridian Bioscience Inc positions in Q2 2013 and 0 closed out, a net change of +163 holders.
Based on aggregated 13F filings for Q2 2013.